MedPath

University Of California, San Francisco

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

C-reactive Protein (CRP)-Guided Management Algorithm for Adults With Acute Cough

Not Applicable
Completed
Conditions
Cough
First Posted Date
2005-09-22
Last Posted Date
2011-05-23
Lead Sponsor
University of California, San Francisco
Target Recruit Count
139
Registration Number
NCT00221351
Locations
🇺🇸

Veterans Affairs Medical Center, Kansas City, Missouri, United States

🇺🇸

Truman Medical Center, Kansas City, Missouri, United States

Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss

Completed
Conditions
Perimenopausal Bone Loss
First Posted Date
2005-09-22
Last Posted Date
2008-05-08
Lead Sponsor
University of California, San Francisco
Target Recruit Count
48
Registration Number
NCT00221312
Locations
🇺🇸

University of California, San Francisco, San Francisco, California, United States

A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma

Phase 1
Completed
Conditions
Central Nervous System Lymphoma
Intraocular Lymphoma
Interventions
Drug: Intraventricular Rituximab Plus MTX
First Posted Date
2005-09-22
Last Posted Date
2015-02-16
Lead Sponsor
University of California, San Francisco
Target Recruit Count
14
Registration Number
NCT00221325
Locations
🇺🇸

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

🇺🇸

MD Anderson Cancer Center, Houston, Texas, United States

🇺🇸

University of California, San Francisco, San Francisco, California, United States

and more 1 locations

Histoblood Group Antigens as a Risk Factor of Asthma

Completed
Conditions
Asthma
Lung Diseases
Interventions
Procedure: Screening
First Posted Date
2005-09-20
Last Posted Date
2013-03-13
Lead Sponsor
University of California, San Francisco
Target Recruit Count
126
Registration Number
NCT00201266
Locations
🇺🇸

University of California, San Francisco, San Francisco, California, United States

Enhancing Collaboration Between Doctors and Patients to Improve Asthma

Not Applicable
Completed
Conditions
Asthma
Lung Diseases
Interventions
Behavioral: Status Reports
First Posted Date
2005-09-20
Last Posted Date
2013-03-11
Lead Sponsor
University of California, San Francisco
Target Recruit Count
139
Registration Number
NCT00201188
Locations
🇺🇸

University of California, San Francisco, Parnassus Campus, San Francisco, California, United States

CJD (Creutzfeldt-Jakob Disease) Quinacrine Study

Phase 2
Completed
Conditions
Creutzfeldt-Jakob Disease
Interventions
Drug: Placebo
First Posted Date
2005-09-16
Last Posted Date
2014-06-09
Lead Sponsor
University of California, San Francisco
Target Recruit Count
69
Registration Number
NCT00183092
Locations
🇺🇸

University of California, San Francisco, San Francisco, California, United States

A Case Management Intervention to Prevent ER Visits in HIV-infected Persons

Not Applicable
Terminated
Conditions
HIV
Interventions
Behavioral: Case manager phone call after an ER visit
First Posted Date
2005-09-16
Last Posted Date
2014-01-23
Lead Sponsor
University of California, San Francisco
Target Recruit Count
612
Registration Number
NCT00187590
Locations
🇺🇸

University Medical Center, Fresno, California, United States

Effect of an Inhaled Corticosteroid on Airway Gene Expression in Asthma

Not Applicable
Completed
Conditions
Asthma
First Posted Date
2005-09-16
Last Posted Date
2008-04-03
Lead Sponsor
University of California, San Francisco
Registration Number
NCT00187499
Locations
🇺🇸

Airway Clinical Research Center, Room 1303 Moffitt, UCSF Medical Center, San Francisco, California, United States

Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors

Phase 2
Completed
Conditions
Glioblastoma Multiforme
Gliosarcoma
Interventions
Procedure: Radiation Therapy
First Posted Date
2005-09-16
Last Posted Date
2017-09-05
Lead Sponsor
University of California, San Francisco
Target Recruit Count
66
Registration Number
NCT00187486
Locations
🇺🇸

UCSF Department of Neurological Surgery, San Francisco, California, United States

Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus Arteriosus

Phase 2
Completed
Conditions
Patent Ductus Arteriosus
First Posted Date
2005-09-16
Last Posted Date
2008-06-04
Lead Sponsor
University of California, San Francisco
Target Recruit Count
100
Registration Number
NCT00187447
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

🇺🇸

University of California San Francisco, Davis, California, United States

🇺🇸

Brown University, Providence, Rhode Island, United States

© Copyright 2025. All Rights Reserved by MedPath